Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregabalin | 3 | 2019 | 13 | 2.030 |
Why?
|
| Analgesics | 3 | 2019 | 118 | 1.840 |
Why?
|
| Pain | 4 | 2019 | 472 | 1.330 |
Why?
|
| Splenic Infarction | 2 | 2020 | 2 | 1.310 |
Why?
|
| Off-Label Use | 2 | 2019 | 17 | 1.300 |
Why?
|
| Terminal Care | 3 | 2018 | 92 | 1.000 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 938 | 0.940 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 772 | 0.870 |
Why?
|
| Teaching Rounds | 1 | 2021 | 5 | 0.840 |
Why?
|
| Education, Medical | 2 | 2021 | 147 | 0.820 |
Why?
|
| Health Care Reform | 3 | 2012 | 62 | 0.820 |
Why?
|
| Ceremonial Behavior | 1 | 2021 | 2 | 0.810 |
Why?
|
| Neuralgia | 2 | 2019 | 27 | 0.780 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 47 | 0.770 |
Why?
|
| Aspirin | 1 | 2022 | 295 | 0.760 |
Why?
|
| Uncompensated Care | 1 | 2020 | 4 | 0.740 |
Why?
|
| Hospitals, Voluntary | 1 | 2020 | 5 | 0.740 |
Why?
|
| Hospitals, Public | 1 | 2020 | 22 | 0.740 |
Why?
|
| Humans | 47 | 2022 | 68525 | 0.730 |
Why?
|
| Physicians | 4 | 2005 | 324 | 0.720 |
Why?
|
| Genetic Testing | 1 | 2021 | 159 | 0.720 |
Why?
|
| Precision Medicine | 1 | 2021 | 111 | 0.720 |
Why?
|
| Abdominal Pain | 1 | 2020 | 97 | 0.710 |
Why?
|
| Chronic Pain | 2 | 2019 | 110 | 0.700 |
Why?
|
| Physician's Role | 3 | 2012 | 116 | 0.690 |
Why?
|
| Antimicrobial Stewardship | 1 | 2019 | 33 | 0.690 |
Why?
|
| Unnecessary Procedures | 3 | 2014 | 49 | 0.690 |
Why?
|
| Calcium Carbonate | 1 | 2018 | 7 | 0.680 |
Why?
|
| Histamine H2 Antagonists | 1 | 2018 | 45 | 0.660 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 91 | 0.660 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 34 | 0.640 |
Why?
|
| Ambulatory Care | 1 | 2020 | 339 | 0.630 |
Why?
|
| Proton Pump Inhibitors | 1 | 2018 | 91 | 0.620 |
Why?
|
| Ethics, Medical | 3 | 2018 | 86 | 0.610 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2017 | 60 | 0.590 |
Why?
|
| United States | 12 | 2022 | 7335 | 0.580 |
Why?
|
| Amines | 1 | 2017 | 98 | 0.580 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 207 | 0.570 |
Why?
|
| Attitude of Health Personnel | 3 | 2005 | 442 | 0.560 |
Why?
|
| Altitude | 1 | 2015 | 17 | 0.540 |
Why?
|
| Primary Health Care | 1 | 2021 | 702 | 0.530 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 208 | 0.530 |
Why?
|
| Sickle Cell Trait | 1 | 2015 | 24 | 0.530 |
Why?
|
| Coronary Artery Bypass | 2 | 2014 | 218 | 0.530 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 43 | 0.510 |
Why?
|
| Health Services Accessibility | 2 | 2012 | 581 | 0.500 |
Why?
|
| Sigmoidoscopy | 1 | 2014 | 38 | 0.500 |
Why?
|
| Medical Futility | 3 | 2018 | 31 | 0.490 |
Why?
|
| Endarterectomy, Carotid | 1 | 2014 | 110 | 0.480 |
Why?
|
| Retinal Detachment | 1 | 2013 | 14 | 0.480 |
Why?
|
| Foramen Ovale, Patent | 1 | 2013 | 21 | 0.460 |
Why?
|
| Fluoroquinolones | 1 | 2013 | 49 | 0.460 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 21 | 0.460 |
Why?
|
| Aminoquinolines | 1 | 2013 | 14 | 0.460 |
Why?
|
| Religion | 1 | 2013 | 23 | 0.460 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 163 | 0.460 |
Why?
|
| Fasting | 1 | 2013 | 75 | 0.450 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2013 | 29 | 0.450 |
Why?
|
| Drug Industry | 2 | 2003 | 54 | 0.450 |
Why?
|
| Delirium | 1 | 2013 | 45 | 0.440 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2010 | 503 | 0.420 |
Why?
|
| Social Responsibility | 1 | 2012 | 39 | 0.420 |
Why?
|
| Secondary Prevention | 1 | 2013 | 291 | 0.410 |
Why?
|
| Water | 1 | 2013 | 228 | 0.410 |
Why?
|
| Telemedicine | 1 | 2020 | 699 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 1026 | 0.400 |
Why?
|
| Stroke | 2 | 2014 | 2161 | 0.390 |
Why?
|
| Prostate-Specific Antigen | 1 | 2011 | 138 | 0.390 |
Why?
|
| Health Behavior | 1 | 2014 | 458 | 0.390 |
Why?
|
| Hospitals | 2 | 2020 | 265 | 0.380 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 38 | 0.380 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 307 | 0.380 |
Why?
|
| Colonic Diseases | 2 | 2008 | 36 | 0.370 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 377 | 0.360 |
Why?
|
| Single-Payer System | 1 | 2009 | 3 | 0.360 |
Why?
|
| Social Values | 1 | 2009 | 34 | 0.350 |
Why?
|
| Perioperative Care | 1 | 2010 | 100 | 0.350 |
Why?
|
| Mass Screening | 2 | 2014 | 837 | 0.350 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 439 | 0.350 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 560 | 0.340 |
Why?
|
| Case Management | 1 | 2009 | 46 | 0.340 |
Why?
|
| United States Food and Drug Administration | 2 | 2021 | 131 | 0.330 |
Why?
|
| Counseling | 1 | 2010 | 279 | 0.330 |
Why?
|
| Drug Approval | 2 | 2019 | 50 | 0.320 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 95 | 0.310 |
Why?
|
| Schools, Medical | 1 | 2009 | 157 | 0.310 |
Why?
|
| Advisory Committees | 2 | 2022 | 73 | 0.310 |
Why?
|
| National Health Insurance, United States | 1 | 2007 | 6 | 0.300 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 124 | 0.300 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 438 | 0.300 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 261 | 0.300 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 76 | 0.300 |
Why?
|
| Preventive Health Services | 2 | 2022 | 86 | 0.300 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2009 | 148 | 0.300 |
Why?
|
| Resource Allocation | 1 | 2007 | 35 | 0.300 |
Why?
|
| Female | 14 | 2020 | 38015 | 0.290 |
Why?
|
| Cystic Fibrosis | 2 | 2008 | 283 | 0.280 |
Why?
|
| Family | 2 | 2005 | 293 | 0.280 |
Why?
|
| Drug Resistance, Viral | 1 | 2005 | 14 | 0.280 |
Why?
|
| Acetamides | 1 | 2005 | 17 | 0.280 |
Why?
|
| Male | 15 | 2020 | 37281 | 0.280 |
Why?
|
| Neuraminidase | 1 | 2005 | 36 | 0.270 |
Why?
|
| Ethics, Professional | 2 | 2018 | 8 | 0.270 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 20 | 0.260 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 778 | 0.260 |
Why?
|
| Influenza, Human | 1 | 2005 | 79 | 0.260 |
Why?
|
| Gynecology | 1 | 2005 | 46 | 0.260 |
Why?
|
| Deception | 1 | 2004 | 18 | 0.250 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 361 | 0.250 |
Why?
|
| Drug Prescriptions | 1 | 2005 | 135 | 0.250 |
Why?
|
| Internal Medicine | 1 | 2005 | 118 | 0.240 |
Why?
|
| Middle Aged | 11 | 2020 | 21119 | 0.240 |
Why?
|
| Marketing | 1 | 2003 | 26 | 0.240 |
Why?
|
| Life Support Care | 1 | 2003 | 12 | 0.240 |
Why?
|
| Vascular Surgical Procedures | 1 | 2005 | 168 | 0.230 |
Why?
|
| Religion and Medicine | 1 | 2003 | 25 | 0.230 |
Why?
|
| Withholding Treatment | 1 | 2003 | 35 | 0.230 |
Why?
|
| Gift Giving | 1 | 2003 | 10 | 0.230 |
Why?
|
| Persistent Vegetative State | 1 | 2003 | 5 | 0.230 |
Why?
|
| Coronary Disease | 1 | 2005 | 358 | 0.230 |
Why?
|
| Marketing of Health Services | 1 | 2003 | 18 | 0.230 |
Why?
|
| Ethics, Clinical | 1 | 2002 | 9 | 0.220 |
Why?
|
| Delivery of Health Care | 1 | 2007 | 445 | 0.220 |
Why?
|
| Hypnotics and Sedatives | 1 | 2003 | 96 | 0.210 |
Why?
|
| Nurses | 1 | 2002 | 53 | 0.210 |
Why?
|
| Cardiovascular System | 1 | 2022 | 85 | 0.200 |
Why?
|
| HLA-B15 Antigen | 1 | 2021 | 2 | 0.200 |
Why?
|
| Medical Records | 1 | 2021 | 121 | 0.200 |
Why?
|
| HLA-B Antigens | 1 | 2021 | 7 | 0.200 |
Why?
|
| Allopurinol | 1 | 2021 | 36 | 0.200 |
Why?
|
| Carbamazepine | 1 | 2021 | 108 | 0.190 |
Why?
|
| Physical Examination | 1 | 2021 | 152 | 0.190 |
Why?
|
| Tax Exemption | 1 | 2020 | 4 | 0.190 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 4843 | 0.180 |
Why?
|
| Aged | 5 | 2020 | 14842 | 0.180 |
Why?
|
| Drug Misuse | 1 | 2019 | 3 | 0.180 |
Why?
|
| Policy | 1 | 2020 | 58 | 0.180 |
Why?
|
| Critical Care | 1 | 2002 | 263 | 0.180 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2019 | 6 | 0.180 |
Why?
|
| Sciatica | 1 | 2019 | 4 | 0.180 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2019 | 8 | 0.180 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2020 | 59 | 0.170 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 33 | 0.170 |
Why?
|
| Radiculopathy | 1 | 2019 | 15 | 0.170 |
Why?
|
| Fibromyalgia | 1 | 2019 | 29 | 0.170 |
Why?
|
| Communication | 1 | 2021 | 329 | 0.170 |
Why?
|
| Low Back Pain | 1 | 2019 | 45 | 0.170 |
Why?
|
| Poverty | 1 | 2020 | 218 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 180 | 0.160 |
Why?
|
| Adolescent | 3 | 2020 | 8903 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 1085 | 0.160 |
Why?
|
| Pain Measurement | 1 | 2019 | 328 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 301 | 0.150 |
Why?
|
| Inappropriate Prescribing | 1 | 2017 | 27 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2017 | 119 | 0.150 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 375 | 0.130 |
Why?
|
| Adult | 8 | 2020 | 21375 | 0.130 |
Why?
|
| Syncope | 1 | 2014 | 23 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2008 | 275 | 0.130 |
Why?
|
| Dizziness | 1 | 2014 | 27 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 186 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 711 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2013 | 92 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 167 | 0.120 |
Why?
|
| Bronchodilator Agents | 1 | 2013 | 43 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2013 | 56 | 0.110 |
Why?
|
| Administration, Topical | 1 | 2013 | 111 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 63 | 0.110 |
Why?
|
| Attitude to Death | 2 | 2003 | 52 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2009 | 2798 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2014 | 453 | 0.110 |
Why?
|
| Risk Factors | 3 | 2014 | 5719 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2019 | 551 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 186 | 0.110 |
Why?
|
| Cost Control | 1 | 2012 | 34 | 0.110 |
Why?
|
| Direct Service Costs | 1 | 2011 | 8 | 0.100 |
Why?
|
| Interprofessional Relations | 2 | 2003 | 188 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 234 | 0.100 |
Why?
|
| Patient Preference | 1 | 2012 | 57 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2014 | 2004 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 503 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2018 | 3702 | 0.100 |
Why?
|
| Algorithms | 2 | 2008 | 1194 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 517 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 929 | 0.090 |
Why?
|
| Lobbying | 1 | 2009 | 11 | 0.090 |
Why?
|
| Private Sector | 1 | 2009 | 18 | 0.090 |
Why?
|
| Asthma | 1 | 2013 | 345 | 0.090 |
Why?
|
| Osteomalacia | 1 | 2009 | 8 | 0.090 |
Why?
|
| Public Opinion | 1 | 2009 | 32 | 0.090 |
Why?
|
| Young Adult | 1 | 2020 | 5708 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2009 | 85 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2012 | 346 | 0.080 |
Why?
|
| American Hospital Association | 1 | 2008 | 6 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 3256 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2008 | 62 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2009 | 200 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2020 | 7264 | 0.080 |
Why?
|
| Postoperative Period | 1 | 2008 | 238 | 0.080 |
Why?
|
| Colectomy | 1 | 2008 | 64 | 0.080 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2007 | 14 | 0.080 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2007 | 9 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 420 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2007 | 77 | 0.070 |
Why?
|
| Rhabdomyolysis | 1 | 2006 | 16 | 0.070 |
Why?
|
| Oseltamivir | 1 | 2005 | 6 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 292 | 0.070 |
Why?
|
| Internet | 1 | 2009 | 390 | 0.070 |
Why?
|
| Coccidioidomycosis | 1 | 2005 | 6 | 0.070 |
Why?
|
| Endemic Diseases | 1 | 2005 | 10 | 0.070 |
Why?
|
| Travel | 1 | 2005 | 38 | 0.070 |
Why?
|
| Paraneoplastic Polyneuropathy | 1 | 2005 | 1 | 0.070 |
Why?
|
| Decision Making | 2 | 2012 | 410 | 0.070 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2005 | 6 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2323 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2007 | 193 | 0.060 |
Why?
|
| Workers' Compensation | 1 | 2004 | 3 | 0.060 |
Why?
|
| Curriculum | 1 | 2009 | 575 | 0.060 |
Why?
|
| Treatment Refusal | 1 | 2004 | 40 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 178 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2007 | 631 | 0.060 |
Why?
|
| Right to Die | 1 | 2003 | 5 | 0.060 |
Why?
|
| Value of Life | 1 | 2003 | 14 | 0.060 |
Why?
|
| Christianity | 1 | 2003 | 16 | 0.060 |
Why?
|
| Judgment | 1 | 2003 | 40 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2003 | 122 | 0.060 |
Why?
|
| Conflict of Interest | 1 | 2003 | 48 | 0.060 |
Why?
|
| Patient Self-Determination Act | 1 | 2002 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2077 | 0.050 |
Why?
|
| Disclosure | 1 | 2003 | 45 | 0.050 |
Why?
|
| Advance Directives | 1 | 2002 | 22 | 0.050 |
Why?
|
| Quinolones | 1 | 2003 | 60 | 0.050 |
Why?
|
| Organizational Policy | 1 | 2002 | 42 | 0.050 |
Why?
|
| Liver | 1 | 2007 | 1118 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 624 | 0.040 |
Why?
|
| HIV Infections | 1 | 2006 | 775 | 0.040 |
Why?
|
| Neoplasms | 1 | 2009 | 1660 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2003 | 596 | 0.040 |
Why?
|
| Child | 1 | 2008 | 6400 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 187 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 1139 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2013 | 304 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 2012 | 22 | 0.030 |
Why?
|
| Patient Safety | 1 | 2013 | 202 | 0.030 |
Why?
|
| Health Resources | 1 | 2012 | 76 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 880 | 0.020 |
Why?
|
| Organotechnetium Compounds | 1 | 2009 | 4 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1582 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 166 | 0.020 |
Why?
|
| Diphosphonates | 1 | 2009 | 39 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 306 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 2007 | 79 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2009 | 331 | 0.020 |
Why?
|
| Coccidioides | 1 | 2005 | 3 | 0.020 |
Why?
|
| Fluconazole | 1 | 2005 | 26 | 0.020 |
Why?
|
| Perineum | 1 | 2005 | 11 | 0.020 |
Why?
|
| Headache | 1 | 2005 | 68 | 0.020 |
Why?
|
| Cough | 1 | 2005 | 65 | 0.020 |
Why?
|
| Biopsy | 1 | 2007 | 539 | 0.020 |
Why?
|
| Pancrelipase | 1 | 2004 | 2 | 0.020 |
Why?
|
| Fever | 1 | 2005 | 96 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2005 | 108 | 0.020 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 51 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 348 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7028 | 0.010 |
Why?
|
| South Carolina | 1 | 2005 | 2750 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 4655 | 0.010 |
Why?
|